Get the latest news, insights, and market updates on DOCS (Doximity, Inc.). Explore the news page 4 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.
Doximity (DOCS) Q2 2026 Earnings Call Transcript
With me on the call today are Jeff Tangney, Co-Founder and CEO of Doximity; and Anna Bryson, CFO. As part of our comments today, we will be making forward-looking statements. Actual results may differ materially, and we disclaim any obligation to update any forward-looking statements or outlook. Nov 27, 2025 - $DOCS
Should Raymond James’ AI-Focused Upgrade Require Action From Doximity (DOCS) Investors?
Earlier this week, Raymond James upgraded its rating on Doximity, emphasizing improved long-term growth potential and opportunities tied to artificial intelligence capabilities. The analyst cited that Doximity’s recent focus on AI monetization and durable gains in market share could strengthen future revenue streams and company positioning. Let's explore how the emphasis on AI-driven monetization may reshape Doximity's investment narrative and its outlook going forward. Find companies with... Nov 23, 2025 - $DOCS
Is Doximity’s Recent 24% Pullback a Chance or a Caution for Investors in 2025?
Wondering if Doximity is a hidden gem or priced to perfection? You are not alone. There is a lot to unpack for curious investors diving into the stock's current value. Recent headlines might have clouded the picture. The stock is up 4.6% over the past year, even after a sharp 24.0% pullback in the last month. Industry news and evolving competitive landscapes have put Doximity back in the spotlight. Analysts point to new partnerships and expanding service offerings as reasons behind the... Nov 22, 2025 - $DOCS
Why Is Doximity (DOCS) Stock Soaring Today
Shares of medical professional network Doximity (NYSE:DOCS) jumped 9.9% in the afternoon session after Raymond James upgraded the stock's rating to Strong Buy, citing a compelling valuation. Nov 21, 2025 - $DOCS
Wall Street is Pounding the Table Over NVDA, CVNA, DOCS
After swinging in red just yesterday, the major indices are regaining lost momentum. All after the Federal Reserve President John Williams suggested that the central bank cut rates in December. He believes the central bank can lower its key interest rate from here, as labor market weakness poses a bigger economic threat than higher inflation. ... Wall Street is Pounding the Table Over NVDA, CVNA, DOCS Nov 21, 2025 - $DOCS
1 Volatile Stock on Our Buy List and 2 We Ignore
A highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south. While some investors embrace risk, mistakes can be costly for those who aren’t prepared. Nov 19, 2025 - $DOCS
Doximity (DOCS): A Closer Look at Valuation Following Recent Share Price Volatility
Doximity (DOCS) shares have been under pressure as investors weigh recent market moves in the broader healthcare and technology sectors. The stock’s performance over the past month reflects shifting sentiment, which has made valuation a focus for those watching the space. See our latest analysis for Doximity. After a sharp 26.6% drop in the past month, Doximity’s recent share price weakness has added to a pattern of fading momentum that has left the stock down 7.4% year-to-date. Yet, when... Nov 16, 2025 - $DOCS
We use cookies and similar technologies to collect and process data such as browsing activity or unique identifiers.
Selecting "Allow All" to help us understand site usage and improve the platform.
Choosing "Essential Cookies Only" enables only the cookies necessary for core site functions, such as staying logged in.
For more information, please see our Privacy Policy.
Continue with Google
Continue with Facebook
Continue with Microsoft
Continue with Apple